Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study

Affiliations

• ¹ The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. dawn.maze@uhn.ca.
• ² Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
• ³ Division of Hematology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
• ⁴ Tom Baker Cancer Centre, Alberta Health Service Calgary Zone, University of Calgary, Calgary, AB, Canada.
• ⁵ Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA.
• ⁶ Myeloma Section, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
• ⁷ Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
• ⁸ Division of Hematology, Dalhousie University, Halifax, NS, Canada.
• ⁹ Jewish General Hospital, McGill University, Montreal, QC, Canada.
• ¹⁰ The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
• ¹¹ Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
• ¹² Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.
• ¹³ Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.